Enter assignee name

EPO Patents = 4

Trademarks = 2

Forward Citations = 22

Loading Chart...

7 inventors (with patents filed for the assignee):

Carlos A Schuler (9 out of 21 patents)

Rangachari Narasimhan (8 out of 8 patents)

Luiz Belardinelli (7 out of 41 patents)

4. Prashanti Madhavapeddi (3 out of 3 patents)

5. Michael Laird Hurrey (2 out of 5 patents)

6. Gregory Marcus (2 out of 3 patents)

7. Miguel Guzman (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 12059414 - Kits and methods for induction of cardioversion in subjects with atrial arrhythmias (2024-08-13),

2. 11547663 - Unit aerosol doses for anticoagulation (2023-01-10),

3. 11020384 - Antiarrhythmic formulation (2021-06-01),

4. 11007185 - Antiarrhythmic formulation (2021-05-18),

5. 10744087 - Method to slow ventricular rate (2020-08-18),

6. 10668015 - Unit aerosol doses for anticoagulation (2020-06-02),

7. 10660578 - Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation (2020-05-26),

8. 10441537 - Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration (2019-10-15),

9. 10045939 - Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration (2018-08-14),

10. 10010294 - Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation (2018-07-03),

11. 8974828 - Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration (2015-03-10),

Incarda Therapeutics is a biopharmaceutical company focused on developing novel therapies for cardiovascular diseases. Our innovative approach aims to provide breakthrough treatments for patients with heart-related conditions. With a deep commitment to research and development, we strive to make a significant impact in the field of cardiology.

This text is generated by artificial intelligence and may not be accurate.